MED15 acts as an oncogene in numerous types of cancer, including hepatocellular carcinoma [39], prostate cancer [40], head and neck squamous cell carcinoma [41], bladder carcinoma [42], and renal carcinoma [22], to promote tumor progression. The gene discussed is MED15; the disease is prostate carcinoma.